Ȩ
¿¬±¸¼Ò ¼Ò°³
¿¬±¸ ¿¬Çõ
¿¬±¸ Ȱµ¿
Æò»ý ±³À°
ÀÚ·á½Ç
»õ¼Ò½Ä
¿¬±¸Á¤º¸ °Ô½ÃÆÇ
ÀÚÀ¯ °Ô½ÃÆÇ
°ü·Ã »çÀÌÆ®
     
 
 
¿¬±¸¿øº° ¿¬±¸»óȲ Àú¼ú ½ÇÀû ¿¬±¸ºñ ¼öÁÖ½ÇÀû
 
     
 

 


Á¤ ¼º ¼ö
Sung-Su Chung, MD MSD PhD

 

ÀÌ ¸§ Á¤ ¼º ¼ö ïËá¡âª
Á÷ À§

Àü³²´ëÇб³ Ä¡°ú´ëÇÐ ±³¼ö
Àü³²´ëÇб³º´¿ø Áø·áó ÁýÁßÄ¡·á½ÇÀå

¿¬¶ôó

¿¬±¸½Ç (062) 220-6885
Áø·á½Ç (062) 220-6893
Fax ;;;; (062) 232-6294
E-mail : chungss@chonnam.ac.kr

 

    CAREER


1985. 1. Àü³²´ëÇб³ Ä¡°ú´ëÇÐ ÀüÀÓ°­»ç
1987. 4. Àü³²´ëÇб³ Ä¡°ú´ëÇÐ Á¶±³¼ö
1991. 4. Àü³²´ëÇб³ Ä¡°ú´ëÇÐ ºÎ±³¼ö
1991. 12. - 1992. 8. ¹Ì±¹ Northwestern University Memorial Hospital °´¿ø±³¼ö
1995. 10. - 1997. 10. Àü³²´ëÇб³ Ä¡°ú´ëÇÐ ÇÐÀå
1995. 10. - ÇöÀç Àü³²´ëÇб³º´¿ø ÁýÁßÄ¡·á½ÇÀå
1996. 4. . Àü³²´ëÇб³ Ä¡°ú´ëÇÐ ±³¼ö

    EDUCATION


1971. 2. ±¤ÁÖÁ¦ÀϰíµîÇб³ Á¹¾÷
1977. 2. Àü³²´ëÇб³ Àǰú´ëÇÐ Á¹¾÷
1983. 2. Àü³²´ëÇб³ ´ëÇпø ÀÇÇм®»ç
1984. 2. Àü³²´ëÇб³º´¿ø ¸¶Ãë°ú Àü°øÀÇ ¼ö·á
1986. 2. .. Àü³²´ëÇб³ ´ëÇпø ÀÇÇйڻç

    ACADEMIC ACTIVITIES


´ëÇѸ¶Ãë°úÇÐȸ (1984)
´ëÇÑÅëÁõÇÐȸ (1988)
´ëÇÑÁßȯÀÚÀÇÇÐȸ (1985)
´ëÇÑÅëÁõ¿¬±¸ÇÐȸ (1989)
´ëÇÑÁ¤¸Æ¸¶ÃëÇÐȸ (1994)
´ëÇѼҾƸ¶ÃëÇÐȸ (1995)
´ëÇÑ»ê°ú¸¶ÃëÇÐȸ (1996)
´ëÇÑÈ£Èí°ü¸®ÇÐȸ (1998)

    RESEARCH TOPICS


Ventilator therapy in acute respiratory distress syndrome
Conscious sedation in patients with acute respiratory
Hemodynamic monitoring in patients with septic shock
Respiratory monitoring in acute respiratory failure
Airway management of traumatized airway

 

    RESEARCH IN PROGRESS - IN PREPARATION


Àü½Å¸¶ÃëÁß È¯ÀÚÀÇ Ã¼À§¿¡ µû¸¥ ½Å°æÇÐÀû ¼Õ»óÀÇ ºñ±³

º¹°­°æ°Ë»ç¸¦ ¹Þ´Â ȯÀÚ¿¡¼­ ketamineÀÌ propofolÀÇ ½ÉÇ÷°ü°è, È£Èí±â°è ¹× °¢¼º½Ã°£¿¡ ¹ÌÄ¡´Â ¿µÇâ

½Å°æ¸¶Ãë¿¡ ´ëÇÑ ºÐ¼®- Àü³²´ëÇб³º´¿ø¿¡¼­ÀÇ »ê°ú¸¶ÃëÀÇ ¹æ¹ý°ú ¼úÈÄ ÅëÁõÁ¶ÀýÀÇ ¹æ¹ý ¹× ºÎÀÛ¿ëÀ» Áß½ÉÀ¸·Î-

Propofol-N2O ¸¶ÃëÁß ¼Ò·®ÀÇ FentanylÀÌ Lightwand »ð°ü¿¡ ÀÇÇÑ Ç÷¿ªÇÐ º¯È­¿¡ ¹ÌÄ¡´Â ¿µÇâ

    RESEARCH IN PROGRESS - SUBMITTED

 

    PUBLICATIONS - JOURNALS (1995.1 ~ 2006.2)


Chung SS, Yoon MH, Choi JL, Bae HB, Yoo KY, Jeong CY, Kim SJ | Antionociceptive effects and synergistic interaction with morphine of intrathecal metabotropic glutamine receptor 2/3 antagonist in the formalin test of rats | Neuroscience Letters 2006;394 :222-226 | 2006. 2.20 | Elsevier Science Ireland Limited

Chung SS, Yoo KY, Hwang J, Jeong SW, Kim SJ, Bae HB, Choi JI, Lee J | Anesthetic requirements and stress hormone responses in spinal cord-injured patients undergoing surgery below the level of injury | Anesth Analg 2006;102 :1223-1228 | 2006. 4.1 | Lippincott Williams & Wilkins

Chung SS, Lee SE, Kim SY, Jeong BC, Kim YR, Bae SJ, Ahn OS, Lee JJ, Song HC, Kim JM, Choy HE, Kweon MN, Rhee JH | A Bacterial Flagellin, Vibrio vulnificus FlaB, Has a Strong Mucosal Adjuvant Activity to Induce Protective Immunity | Infection and Immunity 2006;74:694-702 | 2006. 1.31 | American Society for Microbiology

    ÃÖÁ¾Ã¶, ¹èÈ«¹ü, Á¤¼ºÅÂ, ±è¼®Àç, Á¤¼º¿í, À±¸íÇÏ, Á¤¼º¼ö, À¯°æ¿¬, Á¤Ã¢¿µ, ÃÖÁ¤ÀÏ. ´ë»óÆ÷Áø ÈÄ ¹ß»ýÇÑ ºñ´ëÈäÅÍ¿¡ µ¿¹ÝµÈ ¸¸¼º ÅëÁõ. ´ëÇÑÅëÁõÇÐȸÁö2005;18(2):229-231.

    ±è±¤¼ö, Á¤¼º¿í, °û»óÇö, À±¸íÇÏ, À¯°æ¿¬, Á¤Ã¢¿µ, Á¤¼º¼ö. ½ÉÀ嵿¸Æ¿ìȸ¼ú ÈÄ ¹ß»ýÇÑ ¼º´ë¸¶ºñ - Áõ·Êº¸°í. ´ëÇÑÁßȯÀÚÀÇÇÐȸÁö2005;20:170-3.

    Á¤¼º¿í, ±èâ¸ð, ÃÖÃ¶ÈÆ, ½Åµ¿Áø, ¹èÈ«¹ü, Á¤¼º¼ö, À¯°æ¿¬. Èä°ü »ðÀÔ ÈÄ ¹ß»ýÇÑ ÀçÆØÃ¢¼º ÆóºÎÁ¾: Áõ·Ê º¸°í. ´ëÇÑÁßȯÀÚÀÇÇÐȸÁö2005;20:87-91.

    ¹ÚÁؼ­, ¹ÚÁ¾Àº, Á¤¼ºÅÂ, Á¤¼º¿í, Á¤¼º¼ö, À¯°æ¿¬. °³ÀÇ Á¤»ó ¹× ±âÀý½É±Ù¿¡¼­ ±¹¼Ò ½É±Ù ±â´É°ú »ê¼Ò±ÕÇü¿¡ ¹ÌÄ¡´Â Amrinone°ú dobutamineÀÇ ¿µÇâ. ´ëÇÑÁßȯÀÚÀÇÇÐȸÁö2005;20:170-3.

    ±è±¤¼ö, ¹èÈ«¹ü, ÃÖÁ¾Ã¶, ±è¼®Àç, Á¤¼º¼ö, À¯°æ¿¬, Á¤Ã¢¿µ, Á¤¼º¿í. ³ëÀÎȯÀÚÀÇ ºÎÀ§¸¶Ãë½Ã ÁøÁ¤Áö¼ö¿Í ÀÌÁߺб¤°è¼ö ¹× Propofol È¿°úó ³óµµ¿ÍÀÇ »ó°ü°ü°è. ´ëÇѸ¶Ãë°úÇÐȸÁö2005;49:349-54.

    ¹Ú¼º±Ù, ±èâ¸ð, Á¤¼ºÅÂ, ±è¼®Àç, ½Åµ¿Áø, ¹èÈ«¹ü, ÃÖÁ¤ÀÏ, Á¤¼º¿í, Á¤¼º¼ö, À¯°æ¿¬, Á¤Ã¢¿µ, À±¸íÇÏ. ÁãÀÇ Ã´¼ö°­ ³»·Î Åõ¿©ÇÑ Phosphodiesterase ¾ïÁ¦Á¦ÀÎ ZaprinastÀÇ Æ÷¸£¸»¸° À¯¹ß ÅëÁõ ¹ÝÀÀ ¹× Ç÷¿ªÇп¡ ´ëÇÑ ¿µÇâ. ´ëÇѸ¶Ãë°úÇÐȸÁö2005;48:651-5.

    À̼ºÇå, ¹èÈ«¹ü, Á¤Ã¢¿µ, Á¤¼º¼ö, À¯°æ¿¬. °í·ÉȯÀÚ¿¡¼­ ¸¶ÃëÀ¯µµ½Ã LidocaineÀÌ Propofol¿¡ ÀÇÇÑ Ç÷¿ªÇÐ º¯ÇÏ¿¡ ¹ÌÄ¡´Â ¿µÇâ. ´ëÇѸ¶Ãë°úÇÐȸÁö2005;48:614-8.

    ±èâ¸ð, Á¤¼ºÅÂ, ±è¼®Àç, ¹èÈ«¹ü, ÃÖÁ¤ÀÏ, Á¤¼º¿í, Á¤¼º¼ö, À¯°æ¿¬, Á¤Ã¢¿µ, À±¸íÇÏ. Nicardipine°ú AlfentanilÀÇ È¥ÇÕ Åõ¿©°¡ ±â°ü³» »ð°üÀÇ Ç÷¿ªÇÐÀû ¹ÝÀÀ¿¡ ¹ÌÄ¡´Â ¿µÇâ. ´ëÇѸ¶Ãë°úÇÐȸÁö2005;48: 587-91.

    ÃÖÀç¿í, Á¤¼º¼ö, À̱ݼ÷, ±èº´±¹, ±èÀçÇü, ±¹Àºº°, Àå¹Ì¼±, °í¹Ì°æ, Á¤ ±Ç, ÃÖÈ«¶õ, ±è¿ÁÁØ. ¹é¼­ Çô¿¡¼­ÀÇ 4-nitroquinoline 1-oxide À¯µµ ¹ß¾Ï°úÁ¤¿¡¼­ Bcl-2 °è À¯ÀüÀÚÀÇ ¹ßÇö. ´ëÇѱ¸°­³»°úÇÐȸÁö2005;30(3):301-318.

    Choi JW, Kim BG, Chung SS. Experimental study of Bcl-2 family expression in rat tongue carcinoma. ±¸°­°úÇÐ17(1):87-108.

    ÃÖÀç¿í, Á¤¼º¼ö, À̱ݼ÷, ±èº´±¹, ±èÀçÇü, ±¹Àºº°, Àå¹Ì¼±, °í¹Ì°æ, Á¤ ±Ç, ÃÖÈ«¶õ, ±è¿ÁÁØ. Çô¿¡¼­ÀÇ 4NQO À¯µµ¹ß¾Ï°úÁ¤¿¡¼­ Bcl-2°è À¯ÀüÀÚÀÇ ¹ßÇö. ´ëÇѱ¸°­³»°úÇÐȸÁö2005;30(3):301 - 317.

    Yoon MH, Bae HB, Choi JI, Jeong SW, Chung SS, Yoo KY, Jeong CY, Kim SJ, Chung ST, Kim CM, An TH. Pharmacology 2005; 75:157 - 164.

    Á¤Ã¶¿ø, °û»óÇö, À±¸íÇÏ, Á¤¼º¼ö, Á¤Ã¢¿µ, ÇÏÀÎÈ£. DesfluraneÀÌ ±â°ü³» »ð°ü¿¡ ÀÇÇÑ Ç÷¿ªÇÐ ¹ÝÀÀ¿¡ ¹ÌÄ¡´Â ¿µÇâ. ´ëÇѸ¶Ãë°úÇÐȸÁö 2004;46(6):652-657.

    ÀÓȸ¼ø, ±èº´±¹, ±èÀçÇü, À̱ݼ÷, Á¤¼º¼ö. ¼ö¸éÀå¾ÖÈ£ÈíȯÀÚÀÇ µÎºÎ¹æ»ç¼±ÇÐÀû Ư¡. ´ëÇѱ¸°­³»°úÇÐȸÁö 2004;29(1):79-88.

    Á¤¿¬Áø, ±è¹Ì¿ø, ±è¹Î¼®, ±è¼±Çå, ¹Ú»ó¿ø, ¿ÀÈñ±Õ, ±è¿øÀç, Á¤¼º¼ö. Regulatory mechanisms of calcium influx by the endogenous nitric oxide in salivary acinar cells. The Korean Academy of Oral Biology 2004; 29: 75-82.

    °û»óÇö, Áø¿øÁ¾, ¹èÈ«¹ü, Á¤¼º¿í, Á¤¼º¼ö, Á¤Ã¢¿µ. ÆóÀÇ ÇãÅ» ¹× Àçȯ±â°¡ ÆóºÎÁ¾ Çü¼º¿¡ ¹ÌÄ¡´Â ¿µÇâ. ´ëÇÑÁßȯÀÚÀÇÇÐȸÁö 2004;19(1): 8-19.

¹Ú°æ´ö, À¯°æ¿¬, Á¤¼º¼ö, À±¸íÇÏ. ±â°ü³» »ð°ü½Ã ½ÉÇ÷°ü°è ¹ÝÀÀ¿¡ ´ëÇÑ Alfentanil°ú FentanylÀÇ ¿µÇâ ºñ±³. ´ëÇѸ¶Ãë°úÇÐȸÁö 2003; 45(2): 175-8.

Á¤¼º¼ö, ÀÓȸ¼ø, Á¤¸¸ÅÂ, ±èº´±¹, ±èÀçÇü, Á¤¼º¼ö, ¿ÀÁ¾¼®, °­¹Ì¼±, ±è¿ÁÁØ. Fusobacterium nucleatum¿¡ ÀÇÇØ »ý¼ºµÇ´Â ȲȭÇÕ¹° °ËÃâ ¹æ¹ýÀÇ ºñ±³ ´ëÇѱ¸°­³»°úÇÐȸÁö 2003; 28(2): 137-44.  

±è¿õ¸ð, Á¤¼º¿í, °û»óÇö, Á¤¼º¼ö, Á¤Ã¢¿µ. ±â°ü³»»ð°ü¿¡ ÀÇÇØ ±â°ü½Äµµ·ç:Áõ·Êº¸°í. ´ëÇÑÁßȯÀÚÀÇÇÐȸÁö 2003;18(1): 39-42.  

À¯°æ¿¬, Á¤¼ºÅÂ, ¿Àº´Çö, ÇÏÀÎÈ£. °³¿¡¼­ Slidenafil Citrate°¡ Sodium Nitroprusside¿Í NitroglycerinÀÇ Ç÷¾ÐÇϰ­ÀÛ¿ë¿¡ ¹ÌÄ¡´Â ¿µÇâ. ´ëÇѸ¶Ãë°úÇÐȸÁö 2002;43(2):209-215.

±è¼®Àç, Á¤Ã¢¿µ, Á¤¼º¼ö, ÇÏÀÎÈ£, À¯°æ¿¬. °³½É¼ú ȯÀÚ¿¡¼­ protamine sulphateÀÇ Ç÷¾ÐÇϰ­ÀÛ¿ë¿¡ ¹ÌÄ¡´Â calcium chlorideÀÇ ¿µÇâ. ´ëÇѸ¶Ãë°úÇÐȸÁö 2002;43(2):157-164.

°û»óÇö, ±èÁ¾½Ä, ÃÖÁ¤ÀÏ, Á¤¼º¿í, À±¸íÇÏ, Á¤¼º¼ö, À¯°æ¿¬, Á¤Ã¢¿µ, ÀÓ¿õ¸ð. ÀÏÃøÆóȯ±â½Ã Isoflurane°ú ÈäºÎ°æ¸·¿Ü¸¶Ãë°¡ µ¿¸ÆÇ÷»ê¼ÒÈ­¿¡ ¹ÌÄ¡´Â ¿µÇâ. ´ëÇѸ¶Ãë°úÇÐȸÁö 2002;42(6):747-756.

À±¸íÇÏ, Á¤¼º¼ö, ±èÇü¼®. ô¼ö GabapentinÀÇ Ç×Ä§ÇØÈ¿°ú¿¡ ´ëÇÑ Ã´¼ö ¾Æµå·¹³¯¸°¼º ¹× Äݸ°¼º ±æÇ×Á¦ÀÇ È¿°ú. ´ëÇѸ¶Ãë°úÇÐȸÁö 2002;42(5):677-683.

±è¼®Àç, Á¤¼º¿í, °û»óÇö, Á¤¼º¼ö, ÀÓ¿õ¸ð. ³ëµ¿¸Æ µµ°ü ÈÄ ¹ß»ýÇÑ ¾öÁö ±«»ç -Áõ·Ê º¸°í-. ´ëÇÑÁßȯÀÚÀÇÇÐȸÁö 2002;17(1):25-28.

Yoo KY, Lee JU, Kwak SH, Im WM, Jeong CY, Chung SS, Yoon MH, Jeong SW, Park JT. Effects of intracoronary calcium chloride on regional oxygen balance and mechanical function in normal and stunned myocardium in dogs. Br J Anaesth 2002;88(1):78-86.

ÀÓȸ¼ø, ±èº´±¹, Á¤¼º¼ö. ¿¬·ÉÁõ°¡¿¡ µû¸¥ ½É»óÀ¯µÎÀÇ º¯È­. Àü³²Ä¡´ë³í¹®Áý 2000;12(1): 430-444.

±èÁö¿¬, ±èº´±¹, Á¤¼º¼ö. ±¸°­ÀÛ¿­°¨ ÁõÈıºÈ¯ÀÚ¿¡¼­ Nd-YAG ·¹ÀÌÀúÁ¶»ç¿¡ ´ëÇÑ ±¸°­Á¡¸·ºÎÀ§ÀÇ ÅëÁõÀÎÁöµµ¿Í Á¡¸·¼¼Æ÷°¢È­µµ¿ÍÀÇ °ü°è. Àü³²Ä¡´ë³í¹®Áý 2000;12(1):298-307.

±èº´±¹, Á¤¼º¼ö. ±ÙÀ°¼¼Æ÷ºÐÈ­¿¡ ´ëÇÑ TGF-¥â1°ú OP-1ÀÇ ¾ïÁ¦È¿°ú. Àü³²Ä¡´ë³í¹®Áý 2000;12(1):15-30.

À±¸íÇÏ, °û»óÇö, Á¤¼º¼ö, À¯°æ¿¬, Á¤Ã¢¿µ, ÀÓ¿õ¸ð. ¹é¼­¸¦ ÀÌ¿ëÇÑ Æ÷¸£¸»¸° ÅëÁõ ¸ðÇüÇÏ¿¡¼­ ³ú½Ç³» gabapentinÀÇ È¿°ú. ´ëÇÑÅëÁõÇÐȸÁö 2000;13(2):137-142.

À¯°æ¿¬, ³ë¸í±â, ±è¹Ì°æ, À±¸íÇÏ, Á¤¼º¼ö. °³¿¡¼­ °ü»óµ¿¸Æ³» ¿¡Çdz×ÇÁ¸°ÀÌ ±âÀý½É±ÙÀÇ °ü»óµ¿¸ÆÇ÷·ù·®, °£È­¼º ´ë»ç ¹× ±¹¼Ò½É±Ù±â´É¿¡ ¹ÌÄ¡´Â ¿µÇâ. ´ëÇѸ¶Ãë°úÇÐȸÁö 2000;39(4):568-577.

±è¼ö°ü, Á¤¼º¼ö. Medpor ¸Å½ÄÈÄ Ä¡À¯°úÁ¤¿¡ MethylprednisoloneÀÌ ¹ÌÄ¡´Â ¿µÇâ, ´ëÇѾǾȸ鼺ÇüÀç°Ç¿Ü°úÇÐȸÁö 22(2):142-54, 2000.

Á¤±Ç, À±¸íÇÏ, Á¤¼º¿í, °û»óÇö, Á¤¼º¼ö, Á¤Ã¢¿µ. Á㸦 ÀÌ¿ëÇÑ Æ÷¸£¸»¸° ½ÇÇèÇÏ¿¡¼­ ô¼ö°­³» Ç×Äݸ°¿¡½ºÅ×¶óÁ¦ÀÇ Ç×Ä§ÇØÈ¿°ú. ´ëÇѸ¶Ãë°úÇÐȸÁö 38(5):887-93, 2000.

°û»óÇö, ÃÖÁ¤ÀÏ, Á¤¼º¿í, À±¸íÇÏ, Á¤¼º¼ö, À¯°æ¿¬, Á¤Ã¢¿µ, ÀÓ¿õ¸ð. ÀÏÃø Æó ¸¶Ãë½Ã Desflurane°ú IsofluraneÀÌ µ¿¸ÆÇ÷ »ê¼ÒÈ­¿Í ÆóÀå³» ´Ü¶ô¿¡ ¹ÌÄ¡´Â ¿µÇâ. ´ëÇѸ¶Ãë°úÇÐȸÁö 38(4):623-31, 2000.

±è¼±¹Ì, ¾ç±ÔÈ£, Á¤¼º¼ö, ¿ÀÁ¾¼®. Streptococcus oralisÀÇ ÀΰøÄ¡Å ¾ïÁ¦È¿°ú¿¡ ´ëÇÑ ¿¬±¸. Àü³²Ä¡´ë³í¹®Áý 11(1):105-18, 1999.

±è¼ö°ü, Á¤¼º¼ö. Medpor ¸Å½ÄÈÄ Ä¡À¯°úÁ¤¿¡ MethylprednisoloneÀÌ ¹ÌÄ¡´Â ¿µÇâ. Àü³²Ä¡´ë ³í¹®Áý 11(1):77-104, 1999.

Á¤¼º¿í, ³ë¸í±â, °û»óÇö, À±¸íÇÏ, Á¤¼º¼ö. Pieere-Robin ÁõÈıº ȯ¾ÆÀÇ ¸¶Ãë °æÇè 2¿¹. ¼Ò¾Æ¸¶Ãë 3(1):54-7, 1999.

Á¤¼º¼ö. Àΰø±âµµ. ¼Ò¾Æ¸¶Ãë 3(1):20-3, 1999.

Á¤¼º¿í, È«¼÷Èñ, °û»óÇö, Á¤¼º¼ö, Á¤Ã¢¿µ, ÀÓ¿õ¸ð. ¼º»ó½Å°æÀýÂ÷´ÜÈÄ Áø´ÜÇÑ Àç¹ß¼º ´Ù¹ß¼º ¿¬°ñ¿° -Áõ·Êº¸°í-. ´ëÇѸ¶Ãë°úÇÐȸÁö 36(6):1087-90, 1999.

±èÅ¿±, °û»óÇö, Á¤±Ç, Á¤¼º¼ö, À¯°æ¿¬, Á¤Ã¢¿µ. ±â°èȯ±â º¸Á¶¸¦ ¹Þ´Â ȯÀÚÀÇ ÁøÁ¤À» À§ÇÑ Midazolam°ú PropofolÀÇ ºñ±³. ´ëÇѸ¶Ãë°úÇÐȸÁö 36(6):929-37, 1999.

±è¹Ì°æ, °û»óÇö, Á¤¼º¼ö, Á¤Ã¢¿µ, ÀÓ¿õ¸ð. Desflurane-N2O-O2¿Í Isoflurane-N2O-O2¸¦ ÀÌ¿ëÇÑ ÈíÀÔ¸¶ÃëÀÇ È¸º¹½Ã Ư¼º. ´ëÇѸ¶Ãë°úÇÐȸÁö 36(5):764-70, 1999.

À¯°æ¿¬, ¾ç¼º¿­, ÀÓ¿õ¸ð, Á¤Ã¢¿µ, Á¤¼º¼ö, °û»óÇö. Intracoronary propofol attenuates myocardial but not coronary endothelial dysfunction after brief ischaemia and reperfusion in dogs. Br J Anaesth 82(1):90-6, 1999.

À±¸íÇÏ, È«¼÷Èñ, °û»óÇö, Á¤Ã¢¿µ, Á¤¼º¼ö. ¼Ò¾Æ »ç½Ã ¼ö¼ú ÈÄ ¹ß»ýÇÏ´Â ¿À½É ¹× ±¸Åä¿¡ ´ëÇÑ Propofol°ú EnfluraneÀÇ ¿µÇâ. ´ëÇÑÁ¤¸Æ¸¶ÃëÇÐȸ 2(4):415-9, 1998.

Á¤¼º¼ö. ÁßȯÀÚ¿¡¼­ÀÇ ¿µ¾ç¿ä¹ý. ´ëÇÑÁßȯÀÚÀÇÇÐȸÁö 13(2):163-78, 1998.

Á¤¼º¼ö, °íº´ÀÏ, Á¤¼º¿í, ¹ÚÂùÁø. Àü³²´ëÇб³º´¿øÀÇ ¸¶Ãë¹ßÀü°æÇâ¿¡ °üÇÑ ºÐ¼®. ´ëÇѸ¶Ãë°úÇÐȸÁö 35(1):156-62, 1998.

À±¸íÇÏ, È«¼÷Èñ, °û»óÇö, Á¤Ã¢¿µ, Á¤¼º¼ö. ¼Ò¾Æ »ç½Ã ¼ö¼ú ÈÄ ¹ß»ýÇÏ´Â ¿À½É ¹× ±¸Åä¿¡ ´ëÇÑ Propofol°ú EnfluraneÀÇ ¿µÇâ. ´ëÇѸ¶Ãë°úÇÐȸÁö 35(1):151-5, 1998.

À¯°æ¿¬, ÀÓ¼ºÁø, ½É½ÂÁø, Á¤¼º¼ö, ÀÓ¿õ¸ð. °³¿¡¼­ Protamine Sulphate¿¡ ÀÇÇÑ Ç÷¾Ð Çϰ­ ±âÀü. ´ëÇѸ¶Ãë°úÇÐȸÁö 34(1):27-38, 1998.

Á¤Ã¢¿µ, °û»óÇö, Á¤¼º¼ö, ÀÌÇöÁ¤, ±èÅ¿±. °­È­¼º ±â°üÀý°³¿ë Æ©ºê (Armored Tracheostomy Tube)ÀÇ ³»º®ÆØÃ¢¿¡ ÀÇÇÑ ±âµµÆó¼â. ´ëÇÑÁßȯÀÚÀÇÇÐȸÁö 12(2):169-7, 1997.

¹ÚÂùÁø, Á¤¼º¼ö, Á¤Ã¢¿µ, ÇÑ»óµµ. ÈäºÎ-°Ë»óµ¹±â°áÇÕ ½Ö»ý¾ÆÀÇ ºÐ¸®¼ö¼úÀ» À§ÇÑ ¸¶Ãë°ü¸®. ´ëÇѸ¶Ãë°úÇÐȸÁö 33(1):172-7, 1997.

¹ÚÂùÁø, ¹è°¡¼·, Á¤¼º¼ö. ¸ð·¡Áã¿¡¼­ ÀϽÃÀû ´ë³úÇãÇ÷¿¡ ÀÇÇÑ ÇнÀÀå¾Ö¿¡ ¹ÌÄ¡´Â Pentobarbital Sodium, Ketamine ¹× XylazineÀÇ ¿µÇâ. ´ëÇѸ¶Ãë°úÇÐȸÁö 32(5):715-21, 1997.

Á¤¼º¼ö, ¹ÚÂùÁø, ¹ÚÁؼ­. LidocaineÀÇ ±¸°­³»ºÐ¹«¿Í Á¤ÁÖ°¡ ±â°ü³»»ð°ü¿¡ ÀÇÇÑ Ç÷¾Ð°ú ½É¹Ú¼ö¿¡ ¹ÌÄ¡´Â ¿µÇâ. ´ëÇѸ¶Ãë°úÇÐȸÁö 32(3):403-9, 1997.

°û»óÇö, Á¤¼º¼ö. Àü³²´ëÇб³º´¿ø¿¡¼­ÀÇ ¸¶Ãë 71,901·Ê¿¡ ´ëÇÑ ºÐ¼®. ¿ù°£ ÃÖ½ÅÀÇÇÐ 40(2):31-43, 1997.

Á¤¼º¼ö, Á¤Ã¢¿µ, Á¤»ó¿µ. ¼ö¼úȯÀÚ¿¡¼­ Diclofenac ¥â-dimethyllaminoethanol (Dicknol?)ÀÌ ¼úÈÄ ÅëÁõ, Ç÷¿ªÇÐ ¹× Ç÷¾×ÀÀ°í¿¡ ¹ÌÄ¡´Â ¿µÇâ. ¿ù°£ ÃÖ½ÅÀÇÇÐ 39(9):31-7, 1996.

Á¤¼º¼ö, ÀÓ¿õ¸ð, Á¤Ã¢¿µ, º¯Áö¼ö. °í°üÀý´ëÄ¡¼úȯÀÚ¿¡¼­ Lactated Ringer¿ë¾×°ú 6% hydroxyethyl starch(HAES-steril?) ¿ë¾×ÀÌ Ç÷¿ªÇаú Ç÷¾×¿ä±¸·®¿¡ ¹ÌÄ¡´Â ¿µÇâ. ¿ù°£ ÃÖ½ÅÀÇÇÐ 39(7):30-6, 1996.

Á¤¼º¼ö. Ç÷¿ªÇÐÀÇ °¨½Ã. ´ëÇÑÁßȯÀÚÀÇÇÐȸÁö 11(2):119-31, 1996.

ÃÖ°æÀÚ, Á¤¼º¼ö. Ÿ¾×¼± ¼¼Æ÷¿¡¼­ ³»Àμº »êÈ­Áú¼Ò¿¡ ÀÇÇÑ Ä®½· À¯ÀÔ Á¶Àý ±âÀü. Àü³²Ä¡´ë³í¹®Áý 8(1):177-87, 1996.

¹Ú±¤, Á¤¼º¼ö. µ¿Á¾Å»È¸³Ãµ¿°ÇÁ¶°ñÆíÀ» ÀÌ¿ëÇÑ °¡Åä ÇϾǰñ ºÒ¿¬¼Ó °á¼ÕºÎ ¼öº¹Àç°Ç¿¡ °üÇÑ ¿¬±¸. Àü³²Ä¡´ë³í¹®Áý 8(1):41-64, 1996.

¹ÚÂùÁø, ÀÓ¿õ¸ð, Á¤Ã¢¿µ, À¯°æ¿¬, Á¤¼º¼ö, À±¸íÇÏ. ¼¼±Õ¹è¾çÀ» ÅëÇÑ °æ¸·¿Ü Ä«Åן °ÅÄ¡ÀÇ °¨¿°À§Ç輺¿¡ °üÇÑ ¿¬±¸. Àü³²ÀÇ´ëÀâÁö 32(2):153-6, 1996.

À±¸íÇÏ, ¹è°¡¼·, Á¤Ã¢¿µ, Á¤¼º¼ö. »óº¹ºÎ¼ö¼úÈÄ Á¦Åë¿¡ ´ëÇÑ °æ¸·¿Ü Bypivacaine-Fentanyl°ú Bupivacaine-fentanyl-ClonidineÀÇ È¿°ú. ´ëÇÑÅëÁõÇÐȸÁö 6:38-45, 1996.

À¯°æ¿¬, ÀÓ¿õ¸ð, ¹ÚÁؼ­. Ç×ÀÀ°íÁ¦ »ç¿ë ȯÀÚ¿¡¼­ Áö¼ÓÀû °æ¸·¿Ü Á¦Åë¼úÈÄ ¹ß»ýÇÑ °æ¸·¿Ü Ç÷Á¾ 1¿¹. ´ëÇÑÅëÁõÇÐȸÁö 9(1):271-4, 1996.

Á¤¼º¼ö, À¯°æ¿¬, 俵¹Ì. ¼ö¼úÈÄ ÅëÁõÁ¶ÀýÀ» À§ÇÑ °æ¸·¿Ü Â÷´ÜÈÄ ¹ß»ýÇÑ °íÀ§Ã´ÃßÂ÷´Ü. ´ëÇÑÅëÁõÇÐȸÁö 9(1):260-3, 1996.

Á¤¼º¼ö, ±èż®, Á¤Ã¢¿µ. ÀåÆó¼â¼ö¼úȯÀÚ¿¡¼­ ±â°ü³»»ð°üÁß ¹ß»ýÇÑ ÈíÀμºÆó¿°, ´ëÇѱ¸±ÞÀÇÇÐȸÁö 10(2): 129-32, 1995.

Á¤¼º¼ö, ÇÑ¿µ½Å, À¯°æ¿¬, ÀÓ¿õ¸ð. ÈäºÎ¿Ü»óȯÀÚ¿¡¼­ ôÃß¼ö¼úÁß ¹ß»ýÇÑ ´ëÃøÀÇ ±äÀ强 ±âÈä. ´ëÇѱ¸±ÞÀÇÇÐȸÁö 10(2):123-7, 1995.

Á¤¼º¼ö, ±èº°¾Æ, ÀÓ¼ºÁø, À±¸íÇÏ, ÀÓ¿õ¸ð, ¹ÚÂùÁø. ¼ö¼úÁß Dextran-40 Åõ¿©¿¡ ÀÇÇÑ °ú¹Î¹ÝÀÀ Ä¡Çè. ´ëÇѱ¸±ÞÀÇÇÐȸÁö 10(2):119-21, 1995.

ÀÓ¿õ¸ð, Á¤¼º¼ö, ÀÓ¼ºÁø. ¼ö¼úȯÀÚ¿¡¼­ Àü½Å¸¶ÃëÁß ÀÎÁöºóµµ, ±â°ü³»»ð°üÀÇ ¿ëÀ̼º ¹× ¸¶ÃëÈÄ ÇÕº´ÁõÀÇ Æò°¡. ´ëÇѸ¶Ãë°úÇÐȸÁö 29(4):471-6, 1995.

Á¤¼º¼ö, À±¸íÇÏ, ÀÓ¿õ¸ð, ±èż®. SUCCINYLCHOLINEÀÌ PIPECURIUMÀÇ ÀÛ¿ë¿¡ ¹ÌÄ¡´Â ¿µÇâ. ´ëÇѸ¶Ãë°úÇÐȸÁö 28(5):669-75, 1995.

À±¸íÇÏ, À¯°æ¿¬, Á¤¼º¼ö, Á¤Ã¢¿µ, ÀÓ¿õ¸ð, ¹ÚÂùÁø, ÀÌÁ¦Çõ. Ketorolac Á¤ÁÖ¿ë·®¿¡ µû¸¥ ¼úÈÄ Á¦ÅëÈ¿°ú ºñ±³. ´ëÇÑÅëÁõÇÐȸÁö 8(1):43-50, 1995.

PRESENTATION ( 2000.1 ~ 2005.2 )